Filter
522
Filtered Results: 522
Text search:
UNITAID
Featured
Recommendations
61
New Publications
106
Language
Document type
No document type
215
Studies & Reports
109
Guidelines
96
Manuals
41
Strategic & Response Plan
34
Fact sheets
18
Training Material
4
Brochures
2
Situation Updates
2
Infographics
1
Countries / Regions
Global
42
Congo, Democratic Republic of
18
Africa
14
India
10
Burkina Faso
8
Kenya
7
Benin
7
South Africa
7
Uganda
7
Senegal
6
Myanmar / Burma
6
Cameroon
5
Tanzania
4
Western and Central Europe
4
Brazil
4
Ethiopia
4
Madagascar
4
Malawi
3
Guinea
3
Mozambique
3
Asia
3
West and Central Africa
3
Eastern Europe
3
Zambia
3
Lesotho
2
Ghana
2
Nigeria
2
Niger
2
Haiti
2
Latin America and the Carribbean
2
Germany
2
Middle East and North Africa
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Bangladesh
2
Mali
2
Tajikistan
1
Nepal
1
Colombia
1
Timor Leste/ East Timor
1
Ukraine
1
Sierra Leone
1
Togo
1
Iran
1
Morocco
1
Eastern Europe and Central Asia
1
France
1
Moldova
1
Sri Lanka
1
Russia
1
Central African Republic
1
Chad
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
130
Clinical Guidelines
74
Pharmacy & Technologies
23
Public Health
21
Women & Child Health
15
Key Resources
14
Capacity Building
1
Toolboxes
HIV
103
TB
78
COVID-19
39
Malaria
37
Health Financing Toolbox
26
Pharmacy
23
AMR
13
Rapid Response
11
Ebola & Marburg
9
Mental Health
7
Global Health Education
7
NTDs
6
Planetary Health
5
NCDs
5
Polio
5
Refugee
4
Disability
3
Caregiver
3
Conflict
3
Cholera
2
Natural Hazards
1
Social Ethics
1
Zika
1
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
Este documento de orientação para elaboração de um plano nacional de operacionalização e vacinação (NDVP) apresenta um esquema que auxilia os países a: desenvolver e atualizar o respectivo NDVP para a introdução de vacinas contra a COVID-19; elaborar estratégias para a operacionalizaçã...
Comment donner du poids à vos messages sur la tuberculose
WHO/HTM/STB/2009.57
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
Tuberculosis cases, TB deaths
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m...
Pour atteindre les objectifs de sa stratégie et se
rapprocher de la cible de l’ODD 3 liée aux trois
maladies à l’horizon 2030, le Fonds mondial doit
réunir 18 milliards de dollars US pour sa huitième
reconstitution des ressources. Cette somme est
le minimum requis pour faire progresser...
IHME’s Financing Global Health report provides an overview of health spending around the world, with a special focus on investments in health in low- and middle-income countries. The report examines how this funding for health is changing each year and forecasts how it may change in the future. Fi...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
En su condición de departamento técnico de la OMS para el paludismo, al Programa Mundial sobre Malaria le corresponde una importante función de liderazgo de la respuesta mundial. Por medio de sus acciones directas y su red, tiene la capacidad de conformar el ecosistema de la respuesta al paludism...
